Status: Recruiting
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
To observe the efficacy and toxicities of post-operative (R0/R1) proton radiotherapy for locally advanced primary thymus epithelial malignancies. The primary endpoint was progression-free survival and toxicities, and the secondary endpoint was overall survival and cause-specific survival.
Participants needed: 55
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Jian ChenUpdated: Jun 13, 2025Locations: 1
Eligibility criteria
Patients with stage II-III (Masaoka-Koga) thymus epithelial malignancies without... [+5]
Complicated with other malignant tumors that have not been controlled. [+8]